Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access

• Main Authors: Sabrina Livezey, PharmD, CSP (Author), Nisha B. Shah, PharmD (Author), Robert McCormick, PharmD (Author), Josh DeClercq, MS (Author), Leena Choi, PhD (Author), Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP (Author)
• Format: Book
• Published: American Association of Psychiatric Pharmacists, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Access to pimavanserin, the only Parkinson disease-related psychosis treatment approved by the FDA, is restricted by insurance requirements, a limited distribution network, and high costs. Following initiation, patients require monitoring for safety and effectiveness. The primary objec...